KYMRIAH
KYMRIAH
Approved
DIN Number
02480514
Drug Class
Human
Market Date
May 24, 2019
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02480514
AIG Number0160630001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01XL04 TISAGENLECLEUCEL
Product Specifications
Dosage FormSuspension
Route of AdministrationIntravenous
AHFS Classification26:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TISAGENLECLEUCELActive
Strength: 600000000 CELLS
Monograph: TISAGENLECLEUCEL